Clinical Trials Directory

Trials / Completed

CompletedNCT06180694

Reminiscence Therapy in Individuals With Dementia

Reminiscence Therapy Applied to Individuals With Dementia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Amasya University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

This research will be carried out with the aim of determining the effect of reminiscence therapy applied to individuals with dementia on cognitive functions, anxiety, depression and activities of daily living. The research will be conducted with a pre-test post-test single group, quasi-experimental research design.

Detailed description

Dementia; It is a disease that requires intensive use of health services, has a high care burden, and has medical, social, psychological and economic burdens for the patient, family and society. Dementia is characterized by many disorders in cognitive functions, especially memory, thought and social skills. Progressive disorders in cognitive functions cause behavioral changes, decrease in activities of daily living, and neuropsychiatric symptoms such as anxiety and depression.

Conditions

Interventions

TypeNameDescription
OTHERReminiscence therapyReminiscence therapies will be applied to individuals with dementia in 45-minute sessions once a week for 8 weeks.

Timeline

Start date
2024-08-19
Primary completion
2024-10-20
Completion
2024-11-20
First posted
2023-12-22
Last updated
2025-04-17

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06180694. Inclusion in this directory is not an endorsement.